Brazzell Kim R.'s Insider Trades & SAST Disclosures
Brazzell Kim R.'s most recent trade in Kala Pharmaceuticals Inc was a trade of 45,200 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 6, 2025.
Add Superstar Alert
Note
This is a custom search result for pattern Brazzell Kim R..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 45,200 | 45,200 | - | - | Stock Option (right to buy) | |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 10,100 | 94,864 (0%) | 0% | 0 | Common Stock | |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 7.63 per share. | 06 Jan 2025 | 2,446 | 92,418 (0%) | 0% | 7.6 | 18,663 | Common Stock |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 4.75 per share. | 26 Jun 2024 | 5,489 | 83,982 (0%) | 0% | 4.8 | 26,073 | Common Stock |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 6.09 per share. | 31 May 2024 | 2,002 | 89,471 (0%) | 0% | 6.1 | 12,192 | Common Stock |
|
Kala Pharmaceuticals Inc
Board Meeting |
Kim Brazzell R. | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 29,300 | 29,300 | - | - | Stock Option (right to buy) | |
|
Kala Pharmaceuticals Inc
Board Meeting |
Kim Brazzell R. | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 6,500 | 93,090 (0%) | 0% | 0 | Common Stock | |
|
Kala Pharmaceuticals Inc
Board Meeting |
Brazzell Kim R. | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 6.74 per share. | 04 Jan 2024 | 1,617 | 91,473 (0%) | 0% | 6.7 | 10,899 | Common Stock |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 576 | 576 | - | - | Stock Option (Right to Buy) | |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 12,800 | 18,609 (0%) | 0% | 0 | Common Stock | |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 28.53 per share. | 04 Jan 2023 | 73 | 18,536 (0%) | 0% | 28.5 | 2,083 | Common Stock |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 6.51 per share. | 26 Oct 2022 | 261 | 5,809 (0%) | 0% | 6.5 | 1,699 | Common Stock |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 0.37 per share. | 27 Jun 2022 | 3,144 | 285,201 (0%) | 0% | 0.4 | 1,163 | Common Stock |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 238,000 | 238,000 | - | - | Stock Option (right to buy) | |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 1.30 per share. | 03 Jan 2022 | 3,504 | 288,345 (0%) | 0% | 1.3 | 4,555 | Common Stock |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.80 per share. | 26 Oct 2021 | 12,757 | 291,849 (0%) | 0% | 1.8 | 22,963 | Common Stock |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 5.77 per share. | 28 Jun 2021 | 3,034 | 300,962 (0%) | 0% | 5.8 | 17,506 | Common Stock |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 110,000 | 110,000 | - | - | Stock Option (right to buy) | |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 27,500 | 303,996 (0%) | 0% | 0 | Common Stock | |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2020 | 81,000 | 276,496 (0%) | 0% | 0 | Common Stock | |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 19,000 | 195,496 (0%) | 0% | 0 | Common Stock | |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.34 per share. | 09 Apr 2020 | 47,644 | 176,496 (0%) | 0% | 3.3 | 159,131 | Common Stock |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2020 | 47,644 | 13,508 | - | - | Stock Option (right to buy) | |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.30 per share. | 09 Apr 2020 | 18,247 | 128,852 (0%) | 0% | 2.3 | 41,968 | Common Stock |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2020 | 18,247 | 0 | - | - | Stock Option (right to buy) | |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2020 | 1,880 | 0 | - | - | Stock Option (right to buy) | |
|
Kala Pharmaceuticals Inc
Board Meeting |
R. Kim Brazzell | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.68 per share. | 09 Apr 2020 | 1,880 | 110,605 (0%) | 0% | 0.7 | 1,278 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges